In China, Cialis has become known as the weekender

The erectile dysfunction drug Cialis is making a big bid for market share of the lucrative impotence market in the world's most populated country, China.

Eli Lilly, the manufactures of Cialis, said that they hoped that Chinese married couples who had in the past tried traditional and untested aphrodisiac may now use this tried and tested erectile dysfunction drug.

They also said that the use of Cialis could resolve sexual difficulties in marriages and thus the divorce courts could be avoided.

What we have noticed at Ukmedix News is that the language in which Eli Lilly is promoting Cialis in China is completely different to the way that they promote Cialis, in America and in the European Union.

In view of the fact that society in China is more conservative they have toned down any explicit references to erectile dysfunction and instead concentrated more on promoting Cialis as a relationship healing medication.

The manufacturers of Cialis have also carried out an extensive survey into sexual attitudes of the Chinese people and one thing that they came across was that almost 50 percent of middle aged Chinese couples had at some point experienced sexual difficulties and erectile dysfunction.

They also came across the fact that only about 30 percent of them had considered getting treatment for erectile dysfunction and Eli Lilly are hoping that their new promotional campaign will encourage awareness of impotence problems and get married couples to come forward and receive treatment.

In China, Cialis has become known as 'the weekender' because it lasts considerably longer then Viagra and Levitra the other two erectile dysfunction drugs on the market.

Cialis has been shipped out to over 5,000 pharmacies all around China over the last month and Eli Lilly is hoping that sales will be good, and with an estimated 35 million men in China suffering from erectile dysfunction there are huge financial rewards to be had.

For more news stories about Cialis please click here.